ArticleTargeted oncology2023

Pathological Response and Tumor Immune Microenvironment Remodeling Upon Neoadjuvant ALK-TKI Treatment in ALK-Rearranged Non-Small Cell Lung Cancer.

Nan Zheng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.